Pasithea Therapeutics Corp.

Historical 13F Holders

Symbol
KTTA
CUSIP
70261F202
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 70261F202 since 12/18/2024, largest first.

Filer % of Class Filed
Coastlands Capital LP 13G/A
11.5% 7/1/2026
Event 4/9/2026
Janus Henderson Group PLC 13G 10.0% 12/8/2025
Event 11/28/2025
Vivo Opportunity Fund Holdings, L.P. 13G/A
10.0% 11/16/2026
Event 9/30/2026
Adage Capital Management, L.P. 13G
10.0% 2/12/2026
Event 12/31/2025
Squadron Capital Management LLC 13G/A
9.9% 2/17/2026
Event 12/31/2025
Stonepine Capital Management, LLC 13G/A
8.3% 11/16/2026
Event 9/30/2026
Funicular Funds, LP 13G
7.4% 4/22/2026
Event 4/15/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Intracoastal Capital LLC 13G
4.99% 5/12/2025
Event 5/6/2025
Armistice Capital, LLC 13G/A
4.99% 5/15/2025
Event 3/31/2025
Orca Capital AG 13G/A 4.9% 5/9/2025
Event 5/7/2025
Ameriprise Financial, Inc. 13G/A
4.1% 11/16/2026
Event 9/30/2026
CVI Investments, Inc. 13G/A
3.8% 2/17/2026
Event 12/31/2025
Lawrence Steinman 13D/A 3.1% 3/6/2025
Event 3/1/2025
Opaleye Management Inc. 13G/A
0% 11/6/2026
Event 9/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 25 15.4 M $7.59M
2026 Q2 25 16.8 M $8.66M
2026 Q1 21 12.8 M $9.52M
2025 Q4 25 12.9 M $16.6M
2025 Q3 19 612 k $441k
2025 Q2 12 301 k $217k
2025 Q1 9 79.0 k $99.1k
2024 Q4 8 77.2 k $243k
2024 Q3 7 9.09 k $48.9k
2024 Q2 8 30.0 k $152k
2024 Q1 7 30.1 k $218k